STOCK TITAN

[Form 3] Genenta Science S.p.A. Initial Statement of Beneficial Ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Genenta Science S.p.A. filed an initial ownership report for Chief Executive Officer and 10% owner Pierluigi Paracchi, showing his current equity position rather than any new trades. He reports direct ownership of 2,275,516 Ordinary Shares and 27,000 American Depositary Shares (ADSs), with each ADS representing one ordinary share.

The filing also lists several stock option grants over ADSs: options over 120,000 ADSs at an exercise price of $3.08 expiring in 2034, 80,000 ADSs at $4.36 expiring in 2035, and 180,000 ADSs at $1.48 expiring in 2035. According to the notes, these options vest in equal monthly installments over three years beginning on July 1, 2024, June 4, 2025, and December 18, 2025, respectively, indicating a multi-year equity incentive structure aligned with his leadership role.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Pierluigi Paracchi

(Last)(First)(Middle)
PIAZZA MARIA ADELAIDE DI SAVOIA 1

(Street)
MILAN,20129

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Genenta Science S.p.A. [ GNTA ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares2,275,516D
American Depositary Shares ("ADSs")(1)27,000D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)07/01/2024(2)07/01/2034ADSs120,000$3.08D
Stock Option (right to buy)06/04/2025(3)06/04/2035ADSs80,000$4.36D
Stock Option (right to buy)12/18/2025(4)12/18/2035ADSs180,000$1.48D
Explanation of Responses:
1. Each American Depositary Share represents one ordinary share, no par value, of the Issuer.
2. The stock options vest in equal monthly installments over three-years beginning July 1, 2024.
3. The stock options vest in equal monthly installments over three-years beginning June 4, 2025.
4. The stock options vest in equal monthly installments over three-years beginning December 18, 2025.
/s/ Pierluigi Paracchi03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)
Genenta Science Spa

NASDAQ:GNTA

View GNTA Stock Overview

GNTA Rankings

GNTA Latest News

GNTA Latest SEC Filings

GNTA Stock Data

19.93M
16.26M
Biotechnology
Healthcare
Link
Italy
Milan